AN2 Therapeutics, Inc. (ANTX): SCHEDULE 13G filed Nov 14, 2025

Form type

SCHEDULE 13G

Filing date

Nov 14, 2025

Accession number

0001596468-25-000022

Filer

AN2 Therapeutics, Inc. (CIK 1880438)